semaglutide bowel obstruction class action in louisiana glp-1 Food-induced small bowel obstruction observed a patient with inappropriate use of FDA Adds Intestinal Blockage Reports
Description
Push through days 3-14
Push Health is provider-priced and unbundled
Not everybody responds to the same blood pressure medications
Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that works by mimicking a hormone that the body uses to signal that its full or satisfied
The FDA approved Foundayo (orforglipron) in April 2026 as the first oral GLP-1 weight loss medication that can be taken with food at any time of day
